Publications
162
Citations
555
Est. group size
~9
Recurring co-author estimate
Active years
34
Publishing since 1993
Typically publishes in teams of ~13 · 3% small-team papers (≤3 authors) · across 20 venues
- Serial proteomic characterization of plasma extracellular vesicles (EV) to identify changes that predict outcomes in metastatic castrate-resistant prostate cancer (mCRPC) patients receiving <sup>177</sup> Lu-PSMA-617.
Journal of Clinical Oncology · 2026
- CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancer
Oncotarget · 2026
- CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancer
PubMed Central · 2026
- Supplementary Figure S4 from Germline–Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking <i>ATM</i> to <i>TP53</i> Synthetic Essentiality
2026
- Supplementary Figure S3 from Germline–Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking <i>ATM</i> to <i>TP53</i> Synthetic Essentiality
2026
- Supplementary Figure S5 from Germline–Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking <i>ATM</i> to <i>TP53</i> Synthetic Essentiality
2026
- Supplementary Figure S1 from Germline–Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking <i>ATM</i> to <i>TP53</i> Synthetic Essentiality
2026
- Supplementary Figure S2 from Germline–Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking <i>ATM</i> to <i>TP53</i> Synthetic Essentiality
2026
- Targeted proteomics for the detection of androgen receptor variants in preclinical models of castration-resistant prostate cancer
Clinical Proteomics · 2026
- Germline–Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking <i>ATM</i> to <i>TP53</i> Synthetic Essentiality
Clinical Cancer Research · 2025
- CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer
npj Precision Oncology · 2025
- Proteomic Profiling of Extracellular Vesicles Distinguishes Prostate Cancer Molecular Subtypes
Journal of Extracellular Vesicles · 2025
- Dissecting the functional differences and clinical features of R-spondin family members in metastatic prostate cancer
Oncotarget · 2025
- Proteomic profiling of extracellular vesicles distinguishes prostate cancer molecular subtypes
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Evaluating RSPO2 activation and its association with outcomes and potential role as a driver in double-negative prostate cancer (DNPC).
Journal of Clinical Oncology · 2025
- Figshare×13
- Cancer Research×10
- Head & Neck×6
- Journal of Clinical Oncology×4
- Clinical Cancer Research×3
- Jennifer A. Sinnott
Medicine · The Ohio State University
- Joseph J. Park
Medicine · University of Michigan
- Andrew Delekta
Medicine · University of Michigan
- Dinuka De Silva
Medicine · Indiana University
- Joshi J. Alumkal
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile